Dr. Abbas has broad research experience in cancer biology with a solid background in immunopathology, and is well trained in multidisciplinary research. Dr. Abbas has expertise in genomics, epigenetics and global transcriptional regulation, and utilizing these areas to unfold the complexities of tumor physiopathology.
Dr. Abbas' initial training was in the area of reproductive immunology specifically to understand the immunological paradox - a successful pregnancy - and associated pathologies. This immunology background translates to an understanding of the cancer immune evasion and tumor immune microenvironment. Dr. Abbas' current research is focused on understanding the mechanisms that small cell lung cancer (SCLC) utilizes to escape immune surveillance and to design effective immunotherapeutic approaches to treat this highly aggressive tumor. Dr. Abbas is also studying the genomic and transcriptomic signature of metastatic SCLC using next-generation sequencing approaches to find novel therapeutic targets as well as biomarkers for SCLC.